NOTCH1 and non-small cell lung carcinoma: In patients with completely resected EGFR‐mutated NSCLC, NOTCH1 mutation was identified as a poor prognostic factor for OS in the gefitinib group and may serve as a predictor of a poor response to gefitinib.